acea 1011 has been researched along with quinoxalines in 11 studies
| Studies (acea 1011) | Trials (acea 1011) | Recent Studies (post-2010) (acea 1011) | Studies (quinoxalines) | Trials (quinoxalines) | Recent Studies (post-2010) (quinoxalines) |
|---|---|---|---|---|---|
| 12 | 0 | 1 | 9,887 | 625 | 3,095 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (81.82) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsumoto, RR; Nguyen, D; Truong, DD | 1 |
| Keana, JF; Ludwig, P; Martin, H; McAllister, A; Warner, DS; Weber, E | 1 |
| Keana, JF; Lutfy, K; Weber, E; Woodward, RM | 1 |
| Keana, JF; Kest, B; Liebeskind, JC; Marek, P; Vaccarino, AL; Weber, E | 1 |
| Guastella, J; Huettner, JE; Keana, JF; Tran, M; Weber, E; Woodward, RM | 1 |
| Keana, JF; Lutfy, K; Weber, E | 1 |
| Keana, JF; Kwon, IS; Lutfy, K; Marek, P; Sadowski, B; Weber, E | 1 |
| Balster, RL; Compton, AD; Holcomb, JD; McCallum, SE; Porter, JH; Varvel, SA; Wiley, JL | 1 |
| Vanover, KE | 1 |
| Henriksen, EJ; Jacob, S; Lindborg, KA; Teachey, MK | 1 |
| Fröhlich, K; Schäfer, F; Schmidt, W; Striggow, F; Striggow, V | 1 |
11 other study(ies) available for acea 1011 and quinoxalines
| Article | Year |
|---|---|
Strychnine-insensitive glycine site antagonists attenuate a cardiac arrest-induced movement disorder.
Topics: Animals; Anticonvulsants; Behavior, Animal; Cardiopulmonary Resuscitation; Central Nervous System; Dose-Response Relationship, Drug; Felbamate; Heart Arrest; Male; Myoclonus; Phenylcarbamates; Propylene Glycols; Pyrrolidinones; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Glycine; Stereoisomerism; Strychnine | 1995 |
In vivo models of cerebral ischemia: effects of parenterally administered NMDA receptor glycine site antagonists.
Topics: Animals; Brain Ischemia; Male; Nervous System; Neuroprotective Agents; Quinoxalines; Rats; Rats, Wistar; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate | 1995 |
Inhibition of clonic seizure-like excitatory effects induced by intrathecal morphine using two NMDA receptor antagonists: MK-801 and ACEA-1011.
Topics: Analgesics; Animals; Dizocilpine Maleate; Dose-Response Relationship, Drug; In Vitro Techniques; Injections, Intraperitoneal; Injections, Spinal; Male; Mice; Morphine; Motor Activity; Oocytes; Quinoxalines; Receptors, N-Methyl-D-Aspartate; Seizures; Xenopus laevis | 1994 |
NMDA receptor antagonists, MK-801 and ACEA-1011, prevent the development of tonic pain following subcutaneous formalin.
Topics: Analgesics; Animals; Behavior, Animal; Dizocilpine Maleate; Foot; Formaldehyde; Injections, Subcutaneous; Male; Mice; Mice, Inbred Strains; Pain; Quinoxalines; Receptors, N-Methyl-D-Aspartate | 1993 |
Pharmacology of 5-chloro-7-trifluoromethyl-1,4-dihydro-2,3-quinoxalinedione: a novel systemically active ionotropic glutamate receptor antagonist.
Topics: Analgesics; Animals; Anticonvulsants; Brain; Cells, Cultured; Cloning, Molecular; Excitatory Amino Acid Antagonists; Mice; Neurons; Quinoxalines; Rats; Receptors, Glutamate; RNA, Messenger; Seizures; Xenopus laevis | 1995 |
ACEA-1011, a novel NMDA receptor/glycine site antagonist, produces antinociception but not tolerance in the formalin test in mice.
Topics: Analgesics; Animals; Dose-Response Relationship, Drug; Drug Tolerance; Excitatory Amino Acid Agonists; Formaldehyde; Male; Mice; Pain Measurement; Quinoxalines; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate | 1995 |
Differential sensitivity of mice bred for stress-induced analgesia to morphine and ACEA-1011 in the formalin test.
Topics: Analgesia; Analgesics; Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Formaldehyde; Male; Mice; Mice, Inbred Strains; Morphine; Naloxone; Narcotic Antagonists; Pain Measurement; Quinoxalines; Stress, Psychological; Swimming | 1996 |
Effects of modulation of NMDA neurotransmission on response rate and duration in a conflict procedure in rats.
Topics: 2-Amino-5-phosphonovalerate; Acetamides; Animals; Anti-Anxiety Agents; Chlordiazepoxide; Conditioning, Operant; Conflict, Psychological; Diazepam; Dose-Response Relationship, Drug; Electroshock; Male; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reward; Synaptic Transmission | 1998 |
Interaction of ethanol with excitatory amino acid receptor antagonists in mice.
Topics: Animals; Ataxia; Behavior, Animal; Benzodiazepines; Central Nervous System Depressants; Chlordiazepoxide; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Interactions; Ethanol; Excitatory Amino Acid Antagonists; Hypnotics and Sedatives; Isoquinolines; Male; Mice; Muscle Relaxation; Pentobarbital; Piperazines; Pregnanolone; Psychomotor Performance; Quinoxalines; Receptors, Glutamate; Tetrazoles | 1999 |
Effects of in vitro antagonism of endocannabinoid-1 receptors on the glucose transport system in normal and insulin-resistant rat skeletal muscle.
Topics: Animals; Biological Transport; Female; Glucose; Hypoglycemic Agents; In Vitro Techniques; Insulin Resistance; Muscle, Skeletal; Piperidines; Pyrazoles; Quinoxalines; Rats; Rats, Zucker; Receptor, Cannabinoid, CB1; Rimonabant | 2010 |
Cannabinoid receptor subtypes 1 and 2 mediate long-lasting neuroprotection and improve motor behavior deficits after transient focal cerebral ischemia.
Topics: Animals; Arachidonic Acids; Brain; Brain Infarction; Cannabinoids; Disease Models, Animal; Dose-Response Relationship, Drug; Ectodysplasins; Endocannabinoids; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Indans; Infarction, Middle Cerebral Artery; Leukocyte Common Antigens; Male; Movement Disorders; Neuroprotective Agents; Polyunsaturated Alkamides; Psychomotor Performance; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Sulfonic Acids; Time Factors | 2012 |